Immutep Announces Presentation of Quality of Life Data from EFTISARC-NEO Phase II Trial at ESMO 2026
Quality of life remained stable during neoadjuvant treatment with efti, pembrolizumab and radiotherapy, with statistically significant ...
Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, ...
As a company takes steps to transform the former Homer City Generating Station into what would be the largest natural ...
BioNTech has seen its share price move around in recent years, and with the focus increasingly on its oncology pipeline, the ...
Cardiac contractility modulation therapy continued to reduce heart failure hospitalizations and improved functional class and ...
Inc., a private, US-based biopharmaceutical company committed to supporting the unique needs of patients with chronic ...
Connecting Data Across the Workflow Metadata has long supported content discovery, although its role now extends into ...
Sleep quality affects cardiometabolic health in many ways, and it is important for healthcare professionals to routinely ask ...
IMA402 PRAME bispecific continues to demonstrate encouraging anti-tumor activity in multiple indications, alongside a ...
On Monday, Oct. 19, the Imperial County Data Center Advisory Committee conducted a third review of its bylaws, officially adopting a change in language under their Membership section.
Moderna is rated a Hold, citing valuation concerns, lack of definitive long-term efficacy data, and significant execution and ...
Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results